RECENT NEWS

New research from University of Illinois Urbana-Champaign food scientists suggests certain nanoplastics may make foodborne pathogens more virulent.

A review funded as part of Genomics England’s Diverse Data initiative and led by UCL researchers has outlined how the analytical methods used to process and interpret genomic data play a critical role in promoting health equity.

A new study published by health and care charity The King’s Fund uncovers the tough decisions NHS leaders are making to balance their books and protect patient care.

Fujirebio has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Lumipulse G plasma ratio in vitro diagnostic (IVD) test for the assessment of amyloid pathology in patients being evaluated for Alzheimer’s disease and other causes of cognitive decline.

Life sciences and diagnostics firm Revvity, has chosen Bruntwood SciTech’s Alderley Park as its newest UK hub.

North Bristol NHS Trust and Fujifilm Healthcare Europe are to continue their long-standing relationship, with the establishment of a reference site agreement for the UK featuring the Synapse Pathology solution to support Bristol’s innovative histology practice.

Researchers at Amsterdam University Medical Center (UMC) have taken a big step towards a vaccine for HIV after its first in-human assessment of germline-targeting strategy with a trimer displays positive results.

The Microbiology Society, together with the British Mycological Society, has announced Dr Harry Chown of Imperial College London, UK, as the winner of the 2025 Tony Trinci Award.

A research team at the Korea Institute of Machinery and Materials (KIMM) has developed a compact, rapid pretreatment system capable of liquefying and homogenising solid biological samples in under one minute.

New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment for hormone-sensitive prostate cancer patients.

The Department of Health and Social Care (DHSC) has appointed four experienced executive business leaders to strengthen partnerships with strategic suppliers to health.

Roche has announced plans to invest up to US $550 million in its diagnostics manufacturing site in Indianapolis by 2030.

The new headquarters of UK Biobank, a £60m state-of-the-art laboratory and innovation hub at Manchester Science Park called Greenheys, recently celebrated an important milestone, ‘topping out’ the new building.

A single blood test, designed to pick up chemical signals indicative of the presence of many different types of cancer, could thwart progression to advanced disease while the malignancy is still at an early stage and amenable to treatment in up to half of cases, suggests a new study.

Histofy, a leading UK-based pathology AI company focused on accelerating histopathology workflows in both clinical and pharmaceutical sectors, has announced a strategic partnership with Source BioScience UK Limited, the largest histopathology service provider in the United Kingdom.

Chemists at Massachusetts Institute of Technology (MIT) have found a way to identify a complex sugar molecule in the cell walls of the bacteria that cause tuberculosis.

Genomics England has announced the appointment of Julian Thomas into the new role of Chief Technology and Product Officer.

The UK government has unveiled details of a new tool which it says will speed up cancer diagnosis and treatment, as part of its major reform to the NHS.

A new report published by the UK Health Security Agency (UKHSA) shows current state of health inequalities in England caused by infectious diseases, as well as environmental health hazards.

Molecular diagnostics firm Seegene has revealed some details of its forthcoming CURECA automated PCR system following its recent launch at the European Society of Clinical Microbiology and Infectious Diseases in Vienna, Austria.